Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Total Liabilities (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Total Liabilities for 9 consecutive years, with $126.2 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 6.29% to $126.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $126.2 million through Dec 2025, up 6.29% year-over-year, with the annual reading at $126.2 million for FY2025, 6.29% up from the prior year.
  • Total Liabilities hit $126.2 million in Q4 2025 for Inspire Medical Systems, down from $141.3 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $141.3 million in Q3 2025 to a low of $50.3 million in Q1 2021.
  • Historically, Total Liabilities has averaged $86.6 million across 5 years, with a median of $89.6 million in 2023.
  • Biggest five-year swings in Total Liabilities: fell 2.18% in 2022 and later skyrocketed 66.29% in 2023.
  • Year by year, Total Liabilities stood at $66.0 million in 2021, then rose by 4.29% to $68.9 million in 2022, then soared by 51.44% to $104.3 million in 2023, then increased by 13.8% to $118.7 million in 2024, then grew by 6.29% to $126.2 million in 2025.
  • Business Quant data shows Total Liabilities for INSP at $126.2 million in Q4 2025, $141.3 million in Q3 2025, and $124.4 million in Q2 2025.